ABSI — Recent News Coverage
All news mentioning ABSI in ESEN's AI-graded feed
News stories with ABSI as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on ABSI. See /coverage/ABSI for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-08-11
LOW
NEUTRAL
CORR0.15
Absci anticipates ABS-201 interim proof of concept data in 2H 2026, while guiding cash runway into 2H 2028 (NASDAQ:ABSI)
$ABSI
◈ ESEN AI
ABSI disclosed Q2 2026 earnings guidance alongside a scheduled clinical and financial update. The company anticipates interim proof-of-concept data for ABS-201 in the second half of 2026, a procedural milestone on the c…
SEEKINGALPHA.COM
·
2026-08-11
LOW
NEUTRAL
CORR0.15
Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript
$ABSI
◈ ESEN AI
ABSI's Q2 2026 earnings call transcript represents a scheduled disclosure event rather than a market-moving catalyst. The publication of prepared remarks and management Q&A is procedural in nature, offering investors ac…
MANILATIMES.NET
·
2026-08-11
LOW
BULLISH
CORR0.35
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
$ABSI
◈ ESEN AI
Absci disclosed interim Phase 1 data from its HEADLINE trial of ABS-201, marking a scheduled clinical milestone release rather than an unexpected catalyst. While positive interim readouts can support clinical narrative …
ZACKS.COM
·
2026-07-02
LOW
BULLISH
CORR0.42
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy
$ABSI
◈ ESEN AI
ABSI is being positioned as a momentum candidate by Zacks, suggesting technical strength and positive price action relative to broader indices. Momentum-driven narratives typically signal retail interest and potential s…
SEEKINGALPHA.COM
·
2026-06-24
NEUTRAL
BULLISH
CORR0.42
Absci: Eli Lilly Backs Alopecia Data With Funding, But Risks Remain (NASDAQ:ABSI)
$ABSI
$LLY
◈ ESEN AI
ABSI secured a $100M equity investment from Eli Lilly, catalyzing a 30% single-day rally. The funding validates early-stage alopecia program data from Phase 1 trials, demonstrating safety and pharmacokinetic (PK) profil…
RTTNEWS.COM
·
2026-06-24
HIGH
BULLISH
CORR0.72
Absci Corp Stock Rises 18% After Positive Phase 1 Data For AI-Designed Drug Candidate
$ABSI
◈ ESEN AI
ABSI delivered an 18.8% single-session rally following interim Phase 1 clinical readout for ABS-201, an AI-designed antibody targeting prolactin receptor dysfunction. The magnitude of the move reflects biotech sentiment…
RTTNEWS.COM
·
2026-06-24
LOW
BULLISH
CORR0.45
6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More
$INBX
$PVLA
$MBX
$ABSI
◈ ESEN AI
This article highlights retrospective performance analysis of select biotech equities, focusing on INBX, PVLA, MBX, and ABSI among others. The headline presents extreme historical returns (+700% to +200%) without provid…
MARKETS.BUSINESSINSIDER.COM
·
2026-06-24
NEUTRAL
BULLISH
CORR0.35
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
$ABSI
$LLY
◈ ESEN AI
Absci Corporation has announced a $100 million underwritten equity offering with participation from institutional and strategic investors including Eli Lilly & Company, Adage Capital, BVF Partners, Columbia Threadneedle…
MARKETS.BUSINESSINSIDER.COM
·
2026-06-24
NEUTRAL
BULLISH
CORR0.35
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
$ABSI
◈ ESEN AI
Absci (ABSI) reported positive interim Phase 1 data for ABS-201, a novel prolactin receptor-targeting antibody. The candidate demonstrated favorable safety tolerability across all blinded single ascending dose cohorts, …
INSIDERMONKEY.COM
·
2026-06-21
LOW
NEUTRAL
CORR0.35
Is Absci Corporation (ABSI) A Good Stock To Buy Now?
$ABSI
◈ ESEN AI
ABSI is positioned as a potential acquisition candidate within the synthetic biology and antibody design space, with bulls citing proprietary AI-driven protein engineering capabilities as a competitive moat. The thesis …
FINANCE.YAHOO.COM
·
2026-06-21
LOW
NEUTRAL
CORR0.15
Is Absci Corporation (ABSI) A Good Stock To Buy Now?
$ABSI
◈ ESEN AI
ABSI is a clinical-stage biopharmaceutical entity focused on leveraging artificial intelligence and synthetic biology to accelerate drug discovery workflows. The article presents a bullish thesis circulating among retai…
INSIDERMONKEY.COM
·
2026-06-16
NEUTRAL
BULLISH
CORR0.42
Leerink Starts Coverage on Absci Corporation (ABSI)
$ABSI
◈ ESEN AI
Leerink Partners initiated equity research coverage on ABSI with an Outperform rating and a $12 price target, representing a positive market signal for the synthetic biology platform company. This is a standard catalyst…
INSIDERMONKEY.COM
·
2026-06-14
NEUTRAL
BULLISH
CORR0.72
8 Best Genomics Stocks to Buy According to Analysts
$NTRA
$ABSI
◈ ESEN AI
The announcement of a five-year AI collaboration between Google DeepMind, Google.org, and the Wellcome Sanger Institute signals accelerating institutional capital commitment to genomics innovation. This partnership vali…
EXPLORE OTHER FILTERS